Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SPPL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNASEH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDOA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TARP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX4I1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSP90AB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930531 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EEF1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNPY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on